Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.53 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.52 |
| ▸ | TUBB | P07437 | 2/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.52 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.52 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.52 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.52 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.52 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.52 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.52 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.52 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.52 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.52 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.52 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15824942 | 0.87 | ALDH1A1 (0.51) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL13980532 | 0.85 | ALDH1A1 (0.59) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL11244365 | 0.83 | ALDH1A1 (0.58) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL1186309 | 0.83 | CA12 (0.60) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL10507450 | 0.83 | LMNA (0.60) | ALDH1A1POLBKMT2AMEN1GAA | |
| SCHEMBL11434565 | 0.82 | ALDH1A1 (0.49) | ALDH1A1KMT2AMAPK1MAPTHTT | |
| SCHEMBL27560396 | 0.82 | ALDH1A1 (0.54) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL17373970 | 0.81 | ALDH1A1 (0.56) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL15561341 | 0.81 | ALDH1A1 (0.74) | ALDH1A1POLBAGTR1TUBB4ATUBB | |
| SCHEMBL6117960 | 0.81 | ALDH1A1 (0.67) | ALDH1A1POLBAGTR1TUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109516987-B | Preparation method of avibactam intermediate | 江西富祥药业股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| EP-4605392-A1 | METHODS FOR TREATING CANCER | Antares Therapeutics, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-3898587-B1 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | UNIV FREIBURG ALBERT LUDWIGS (DE) | 2024-06-26 | — | — | EP | disclosed |
| EP-3898587-B1 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | UNIV FREIBURG ALBERT LUDWIGS (DE) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024086809-A1 | METHODS FOR TREATING CANCER | SCORPION THERAPEUTICS, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| US-20220055989-A1 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | ALBERT LUDWING UNIV FREIBURG (DE) | 2022-02-24 | — | — | US | disclosed |
| US-20220055989-A1 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | ALBERT LUDWING UNIV FREIBURG (DE) | 2022-02-24 | — | — | US | disclosed |
| EP-3898587-A1 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | Albert-Ludwigs-Universität Freiburg (DE) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020127846-A9 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | ALBERT LUDWIG UNIVERSITÄT FREIBURG (DE) | 2021-08-12 | — | — | WO | disclosed |
| EP-2897599-B1 | SUBSTITUTED ALKYL DIARYL DERIVATIVES, METHODS OF PREPARATION AND USES | UNIV TEMPLE (US) | 2020-12-30 | — | — | EP | disclosed |
| WO-2000073264-A1 | CELL PROLIFERATION INHIBITORS | ABBOTT LABORATORIES (US) | 2000-12-07 | — | — | WO | disclosed |
| US-5359132-A | Process for the preparation of sodium salts of aromatic sulphinic acids containing nitro groups | BAYER AKTIENGESELLSCHAFT (DE) | 1994-10-25 | — | — | US | disclosed |
| US-5134061-A | Nondiffusing \"building blocks\" (couplers, development inhibitors etc.) having a sulfonamide group and a secondary branched alkyl of 14 carbons or more; low-melting; crystal growth inhibitors; high-density color | AGFA GEVAERT AKTIENGESELLSCHAFT (DE) | 1992-07-28 | — | — | US | disclosed |
| US-4831194-A | Process for the preparation of nitrodiaryl sulfoxides | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1989-05-16 | — | — | US | disclosed |
| US-4710323-A | Nitrodiaryl sulfoxide derivatives, process for their preparation and pharmaceutical and pesticidal compositions containing them as active ingredient | RICHTER GEDEON VEGYESZETI GYAR RT (HU) | 1987-12-01 | — | — | US | disclosed |
| US-4623484-A | Process for peptide synthesis | RESEARCH CORPORATION (US) | 1986-11-18 | — | — | US | disclosed |
| US-4575541-A | Polymer with sulfone-benzene appendage | RESEARCH CORPORATION (US) | 1986-03-11 | — | — | US | disclosed |
| US-4211776-A | ANTIEMETICS | CHOAY S.A. (FR) | 1980-07-08 | — | — | US | disclosed |
| US-4132786-A | ANTIEMETICS, ANTICONVULSANTS, ANESTHETICS, ANTIBIOTICS | MOREAU ROBERT C | 1979-01-02 | — | — | US | disclosed |
| US-4041051-A | 1-AMINO-4-HYDROXY-2-(P-METHOXY OR ETHOXY-BENZENESULFONYLOXY)-ANTHRAQUINONE | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220055989-A1 | CONDENSED PYRROLES AS NOVEL BROMODOMAIN INHIBITORS | BRD4, BRPF3, BRD2 | ALDH1A1 3347/4885POLB 61/4885AGTR1 2028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.